New appointments for Mene Pangalos reflect AstraZeneca’s ongoing commitment to UK science

Friday, 13 November 2015

New appointments for Mene Pangalos reflect AstraZeneca’s ongoing commitment to UK science

Yesterday it was announced that Dr Mene Pangalos, Executive Vice President of our IMED Biotech Unit, has accepted two prestigious appointments reflecting AstraZeneca’s long standing commitment to strengthening UK science. 

With immediate effect, Mene will join the Board of the Precision Medicine Catapult - the newly established Cambridge based centre designed to shape the future of precision medicine research in the UK.   In his role as a Non-Executive Director Mene will help set the strategic direction of the Precision Medicine Catapult, providing a pharmaceutical industry perspective on how to ensure the UK can remain at the cutting edge of precision medicine science.

Alongside this appointment, Mene has been elected as an Official Fellow of Clare Hall College in the University of Cambridge.  As a Fellow of the College, Mene will support the Governing Body, with a particular focus on more open research where scientists from industry and academia can work side by side.

On sharing the news with AstraZeneca colleagues Mene commented: “I’m delighted to receive these two appointments.  Although they are a great personal honour, I believe they are testament to the quality of our science, our pioneering approach to personalised healthcare and our long standing commitment to strengthening the UK life science sector.”

tags

  • Partnering
  • Science